1. Home
  2. SCLXW vs SLDPW Comparison

SCLXW vs SLDPW Comparison

Compare SCLXW & SLDPW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scilex Holding Company

SCLXW

Scilex Holding Company

N/A

Current Price

$0.20

Market Cap

0.0

Sector

Health Care

ML Signal

N/A

Logo Solid Power Inc. Warrant

SLDPW

Solid Power Inc. Warrant

HOLD

Current Price

$0.08

Market Cap

0.0

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCLXW
SLDPW
Founded
N/A
2011
Country
United States
United States
Employees
34
230
Industry
Biotechnology: Pharmaceutical Preparations
Electrical Products
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SCLXW
SLDPW
Price
$0.20
$0.08
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
4.9K
32.8K
Earning Date
03-07-2025
02-27-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$55,152,000.00
$18,026,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
22.02
N/A
52 Week Low
$0.05
$0.08
52 Week High
$0.64
$2.33

Technical Indicators

Market Signals
Indicator
SCLXW
SLDPW
Relative Strength Index (RSI) 57.69 36.64
Support Level $0.11 N/A
Resistance Level $0.21 $0.28
Average True Range (ATR) 0.02 0.02
MACD 0.01 -0.00
Stochastic Oscillator 92.12 6.12

Price Performance

Historical Comparison
SCLXW
SLDPW

About SCLXW Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.

About SLDPW Solid Power Inc. Warrant

Solid Power Inc develops solid-state battery technology and manufacturing processes. Its sulfide-based solid electrolyte material replaces the liquid or gel electrolyte used in traditional lithium-ion battery cells and enables improvement in energy density, battery life and safety performance. The company produces electrolytes on two pilot manufacturing lines using a batch manufacturing process for customer sampling and internal cell development, and manufactures solid-state cells on pre-pilot and pilot cell manufacturing lines. Its cell manufacturing processes are developed around industry-standard lithium-ion battery manufacturing processes and equipment, and it manufactures all cell designs, including cathodes and anodes, using materials sourced from external suppliers.

Share on Social Networks: